Treatment Information

Back

Ovarian Cancer treatment details. Chemotherapy, Surgery.

Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.

Survival: monthsCountry:Japan
Toxiciy Grade:4City/State/Province:Nishinomiya, Hyogo
Treatments:Chemotherapy, SurgeryHospital:Hyogo College of Medicine
Drugs:Journal:Link
Date:Mar 2013

Description:

Patients:
This phase 2 study involved 37 advanced ovarian cancer patients with a median age of 55 years.

Treatment:
Patients were treated with interval debulking surgery and chemotherapy with carboplatin, cisplatin, and paclitaxel.

Toxicities:
The most severe toxicities were of grade 4 and included leukopenia, neutropenia, and nerve toxicity.

Results:
The median overall survival was 56.6 months.

Correspondence: Dr. Hiroshi Tsubamoto; email: tsuba@hyo-med.ac.jp



Back